Shares of Amprius Technologies, Inc. (NYSE:AMPX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and eight have issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $20.25.
A number of analysts recently commented on the company. Craig Hallum lifted their price objective on Amprius Technologies from $17.00 to $21.00 and gave the stock a “buy” rating in a research report on Friday, March 6th. Needham & Company LLC reiterated a “buy” rating and set a $20.00 price objective on shares of Amprius Technologies in a research report on Tuesday, March 10th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a research report on Monday, April 20th. William Blair reiterated an “outperform” rating on shares of Amprius Technologies in a research report on Friday, March 6th. Finally, Northland Securities set a $24.00 price objective on Amprius Technologies in a research report on Monday.
Read Our Latest Research Report on Amprius Technologies
Amprius Technologies News Roundup
- Positive Sentiment: Northland Securities turned more constructive on longer-term profitability, projecting Amprius could earn $0.23 per share in FY2028, $0.30 in FY2029, and $0.43 in FY2030, suggesting significant earnings potential if execution improves.
- Positive Sentiment: Northland also raised its Q4 2027 EPS estimate to $0.03 from $0.02, indicating modestly better expectations for future quarterly profitability.
- Neutral Sentiment: HC Wainwright and Northland largely kept the near-term outlook subdued, with FY2026 and FY2027 estimates still calling for small losses or breakeven results, which keeps the story centered on future rather than immediate earnings power.
- Negative Sentiment: Northland lowered its FY2026 EPS estimate to $(0.10) from $(0.08), and HC Wainwright also trimmed its FY2026 and FY2027 forecasts, reinforcing that profitability likely remains a few years away.
Insiders Place Their Bets
In other news, Director Steven Chu sold 155,565 shares of Amprius Technologies stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $18.50, for a total value of $2,877,952.50. Following the transaction, the director directly owned 127,339 shares of the company’s stock, valued at $2,355,771.50. The trade was a 54.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Wen Hsuan Hsieh sold 413,146 shares of Amprius Technologies stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $18.44, for a total value of $7,618,412.24. Following the completion of the transaction, the director directly owned 44,444 shares in the company, valued at $819,547.36. This represents a 90.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 2,539,829 shares of company stock worth $42,323,376 over the last 90 days. Corporate insiders own 5.10% of the company’s stock.
Hedge Funds Weigh In On Amprius Technologies
Several hedge funds and other institutional investors have recently modified their holdings of AMPX. Voloridge Investment Management LLC acquired a new position in shares of Amprius Technologies in the 3rd quarter valued at about $19,737,000. BNP Paribas Financial Markets lifted its position in Amprius Technologies by 1,117.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company’s stock worth $20,450,000 after acquiring an additional 1,784,291 shares in the last quarter. Vanguard Group Inc. lifted its position in Amprius Technologies by 37.0% during the 3rd quarter. Vanguard Group Inc. now owns 6,512,620 shares of the company’s stock worth $68,513,000 after acquiring an additional 1,757,395 shares in the last quarter. Norges Bank acquired a new position in Amprius Technologies during the 4th quarter worth approximately $10,295,000. Finally, Invesco Ltd. lifted its position in Amprius Technologies by 113.3% during the 3rd quarter. Invesco Ltd. now owns 2,379,384 shares of the company’s stock worth $25,031,000 after acquiring an additional 1,263,846 shares in the last quarter. 5.04% of the stock is owned by institutional investors and hedge funds.
Amprius Technologies Stock Down 7.1%
Shares of AMPX stock opened at $17.48 on Monday. Amprius Technologies has a fifty-two week low of $2.34 and a fifty-two week high of $22.80. The stock has a market cap of $2.40 billion, a P/E ratio of -58.28 and a beta of 2.20. The business has a fifty day simple moving average of $18.05 and a 200-day simple moving average of $13.40.
Amprius Technologies (NYSE:AMPX – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). The firm had revenue of $28.54 million during the quarter, compared to analysts’ expectations of $25.72 million. Amprius Technologies had a negative net margin of 43.98% and a negative return on equity of 17.48%. On average, sell-side analysts anticipate that Amprius Technologies will post -0.07 earnings per share for the current year.
About Amprius Technologies
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
Recommended Stories
- Five stocks we like better than Amprius Technologies
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
